Rijpkema M - Search Results

1

PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery.

Derks YHW, Löwik DWPM, Sedelaar JPM, Gotthardt M, Boerman OC, Rijpkema M, Lütje S, Heskamp S. Derks YHW, et al. Among authors: rijpkema m. Theranostics. 2019 Sep 20;9(23):6824-6839. doi: 10.7150/thno.36739. eCollection 2019. Theranostics. 2019. PMID: 31660071 Free PMC article. Review.

2

Radiolabeled imaging probes targeting angiogenesis for personalized medicine.

Terry SY, Rijpkema M, Abiraj K, van der Graaf WT, Oyen WJ, Boerman OC. Terry SY, et al. Among authors: rijpkema m. Curr Pharm Des. 2014;20(14):2293-307. doi: 10.2174/13816128113196660665. Curr Pharm Des. 2014. PMID: 24025101 Review.

3

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.

Lütje S, Rijpkema M, Franssen GM, Fracasso G, Helfrich W, Eek A, Oyen WJ, Colombatti M, Boerman OC. Lütje S, et al. Among authors: rijpkema m. J Nucl Med. 2014 Jun;55(6):995-1001. doi: 10.2967/jnumed.114.138180. Epub 2014 Apr 3. J Nucl Med. 2014. PMID: 24700882 Free article.

4

Preclinical imaging in bone tissue engineering.

Ventura M, Boerman OC, de Korte C, Rijpkema M, Heerschap A, Oosterwijk E, Jansen JA, Walboomers XF. Ventura M, et al. Among authors: rijpkema m. Tissue Eng Part B Rev. 2014 Dec;20(6):578-95. doi: 10.1089/ten.TEB.2013.0635. Epub 2014 May 29. Tissue Eng Part B Rev. 2014. PMID: 24720381 Review.

5

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.

Muselaers CH, Stillebroer AB, Rijpkema M, Franssen GM, Oosterwijk E, Mulders PF, Oyen WJ, Boerman OC. Muselaers CH, et al. Among authors: rijpkema m. J Nucl Med. 2014 Jun;55(6):1035-40. doi: 10.2967/jnumed.114.137356. Epub 2014 Apr 21. J Nucl Med. 2014. PMID: 24752673 Free article.

6

Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

Lütje S, Rijpkema M, Helfrich W, Oyen WJ, Boerman OC. Lütje S, et al. Among authors: rijpkema m. Mol Imaging Biol. 2014 Dec;16(6):747-55. doi: 10.1007/s11307-014-0747-y. Mol Imaging Biol. 2014. PMID: 24849133 Review.

7

SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody.

Rijpkema M, Oyen WJ, Bos D, Franssen GM, Goldenberg DM, Boerman OC. Rijpkema M, et al. J Nucl Med. 2014 Sep;55(9):1519-24. doi: 10.2967/jnumed.114.142141. Epub 2014 Jun 30. J Nucl Med. 2014. PMID: 24982436 Free article.

8

Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.

van de Watering FC, Rijpkema M, Perk L, Brinkmann U, Oyen WJ, Boerman OC. van de Watering FC, et al. Among authors: rijpkema m. Biomed Res Int. 2014;2014:203601. doi: 10.1155/2014/203601. Epub 2014 May 28. Biomed Res Int. 2014. PMID: 24991539 Free PMC article. Review.

9

Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.

Lütje S, Rijpkema M, Goldenberg DM, van Rij CM, Sharkey RM, McBride WJ, Franssen GM, Frielink C, Helfrich W, Oyen WJ, Boerman OC. Lütje S, et al. Among authors: rijpkema m. Cancer Res. 2014 Nov 1;74(21):6216-23. doi: 10.1158/0008-5472.CAN-14-0594. Epub 2014 Sep 24. Cancer Res. 2014. PMID: 25252911

10

Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery.

Rijpkema M, Boerman OC, Oyen WJ. Rijpkema M, et al. Curr Drug Targets. 2015;16(6):625-33. doi: 10.2174/1389450115666141029234200. Curr Drug Targets. 2015. PMID: 25355181 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters